2.6 C
London
Monday, December 6, 2021

Coronavirus vaccine. EMA: A third dose of Moderna can be given to people from 18 years of age

Must read

- Advertisement -


The European Medicines Agency (EMA) has concluded that a booster dose of Moderna’s Spikevax coronavirus vaccine may be considered for adults 18 years of age and older. It consists of half the dose used in the primary immunization schedule.

The EMA reported that the third dose of Spikevax, given 6 to 8 months after the second dose, led to an increase in antibody levels in adults whose levels were waning. The booster dose is half the dose used in the primary immunization schedule.

WATCH TVN24 ON THE INTERNET ON TVN24 GO

A booster dose of coronavirus vaccine

“The current data show that the pattern of side effects after the booster dose is similar to that after the second dose,” the Agency said.

- Advertisement -

“The risk of heart inflammation or other very rare side effects after a booster dose is closely monitored. As with all medicines, EMA will continue to analyze all data on the safety and efficacy of Spikevax,” it added.

EMA: a booster dose may be given 6 months after the second dose

At national level, public health authorities may make official recommendations for the use of booster doses, taking into account the local epidemic situation as well as data on the efficacy and safety of the booster dose.

Earlier this month, EMA concluded that a booster dose of BioNTech / Pfizer vaccines could be considered at least six months after the second dose in people 18 years of age and older. in addition she recommended passing additional dose of Comirnaty and Spikevax in people with severely weakened immune systems, at least 28 days after the second dose.

Main photo source: Leszek Szymański / PAP



Source link

More articles

- Advertisement -

Latest article